MichelleMiranKimMD

Radiation Oncology • Ann Arbor, MI

Physician

Join to view full profile

Dr. Kim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kim's full profile

Already have an account?

Office
1500 E Medical Center Drive
Ann Arbor, MI 48109
Phone+1 734-936-4300

Fax+1 517-789-5939

Education & Training

University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 2009 - 2013
The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 2008 - 2009
Case Western Reserve University School of MedicineClass of 2008

Certifications & Licensure

MI State Medical License 2013 - 2026
TX State Medical License 2013 - 2017
OH State Medical License 2008 - 2009
American Board of Radiology Radiation Oncology

Clinical Trials

Dose-Escalation Study of RRx-001 in Combination With Whole Brain Radiation in Subjects With Brain Metastases Start of enrollment: 2015 Feb 06
Completed
Phase 1
Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2020 Nov 04
Recruiting
Phase 2
Roles: Contact, Principal Investigator

Publications & Presentations

PubMed

Extended nnU-Net for Brain Metastasis Detection and Segmentation in Contrast-Enhanced Magnetic Resonance Imaging With a Large Multi-Institutional Data Set.
Youngjin Yoo, Eli Gibson, Gengyan Zhao, Thomas J Re, Hemant Parmar
International Journal of Radiation Oncology, Biology, Physics. 2025-01-01
The oncological role of resection in newly diagnosed diffuse adult-type glioma defined by the WHO 2021 classification: a Review by the RANO resect group.
Philipp Karschnia, Jasper K W Gerritsen, Nico Teske, Daniel P Cahill, Asgeir S Jakola
The Lancet. Oncology. 2024-09-01
AB036. Targeting glioblastoma de-novo purine metabolism to overcome chemoradiation resistance: an interim result of phase 0/1 clinical trial in newly diagnosed and rec...
Yoshie Umemura, Nathan Clarke, Wajd Al-Holou, Ameer Elaimy, Andrew Scott
Chinese Clinical Oncology. 2024-08-01

Press Mentions

Brain Cancer Patient Finds Hope with Emerging New TherapyDecember 6th, 2018